Artificial intelligence-driven identification of morin analogues acting as CaV1.2 channel blockers: Synthesis and biological evaluation

Bioorg Chem. 2023 Feb:131:106326. doi: 10.1016/j.bioorg.2022.106326. Epub 2022 Dec 17.

Abstract

Morin is a vasorelaxant flavonoid, whose activity is ascribable to CaV1.2 channel blockade that, however, is weak as compared to that of clinically used therapeutic agents. A conventional strategy to circumvent this drawback is to synthesize new derivatives differently decorated and, in this context, morin-derivatives able to interact with CaV1.2 channels were found by employing the potential of PLATO in target fishing and reverse screening. Three different derivatives (5a-c) were selected as promising tools, synthesized, and investigated in in vitro functional studies using rat aorta rings and rat tail artery myocytes. 5a-c were found more effective vasorelaxant agents than the naturally occurring parent compound and antagonized both electro- and pharmaco-mechanical coupling in an endothelium-independent manner. 5a, the series' most potent, reduced also Ca2+ mobilization from intracellular store sites. Furthermore, 5a≈5c > 5b inhibited Ba2+ current through CaV1.2 channels. However, compound 5a caused also a concentration-dependent inhibition of KCa1.1 channel currents.

Keywords: Ca(2+) mobilization; Ca(V)1.2 channels; Docking simulations; Endothelium; Morin; Target fishing.

MeSH terms

  • Animals
  • Artificial Intelligence*
  • Calcium Channel Blockers* / chemistry
  • Calcium Channel Blockers* / pharmacology
  • Calcium Channels, L-Type* / metabolism
  • Flavonoids* / pharmacology
  • Rats
  • Vasodilation*
  • Vasodilator Agents* / chemistry
  • Vasodilator Agents* / pharmacology

Substances

  • Flavonoids
  • L-type calcium channel alpha(1C)
  • morin
  • Vasodilator Agents
  • Calcium Channel Blockers
  • Calcium Channels, L-Type